This Solicitation opportunity from Department Of Defense was posted on June 3, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
BUPIVACAINE HYDROCH
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the procurement of Bupivacaine Hydrochloride, identified under the National Stock Number 6505-00-138-7347, with a quantity of one unit requested under purchase request number 7017022142. The solicitation, numbered SPE2DP-26-T-3671, was issued by the Defense Logistics Agency, part of the Department of Defense, and posted on June 3, 2026. Interested parties were required to submit their responses by June 9, 2026. This federal contract does not specify any type of set-aside status or NAICS code, and the place of performance details are not provided. The contract details indicate it is a solicitation for the supply of the specified pharmaceutical product, managed by a federal agency without additional organizational, location, or contact specifics detailed in the available information. The procurement process appears straightforward with a single unit ordered and standard timelines for solicitation and response. The official solicitation and additional documents can be accessed via the provided government procurement website link.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
